1. Home
  2. YOSH vs ARTL Comparison

YOSH vs ARTL Comparison

Compare YOSH & ARTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • YOSH
  • ARTL
  • Stock Information
  • Founded
  • YOSH 2016
  • ARTL 2011
  • Country
  • YOSH United States
  • ARTL United States
  • Employees
  • YOSH N/A
  • ARTL N/A
  • Industry
  • YOSH Restaurants
  • ARTL Biotechnology: Pharmaceutical Preparations
  • Sector
  • YOSH Consumer Discretionary
  • ARTL Health Care
  • Exchange
  • YOSH Nasdaq
  • ARTL Nasdaq
  • Market Cap
  • YOSH 4.5M
  • ARTL 3.7M
  • IPO Year
  • YOSH 2022
  • ARTL N/A
  • Fundamental
  • Price
  • YOSH $3.49
  • ARTL $1.21
  • Analyst Decision
  • YOSH
  • ARTL Strong Buy
  • Analyst Count
  • YOSH 0
  • ARTL 2
  • Target Price
  • YOSH N/A
  • ARTL $5.50
  • AVG Volume (30 Days)
  • YOSH 22.1K
  • ARTL 28.9K
  • Earning Date
  • YOSH 11-19-2024
  • ARTL 11-12-2024
  • Dividend Yield
  • YOSH N/A
  • ARTL N/A
  • EPS Growth
  • YOSH N/A
  • ARTL N/A
  • EPS
  • YOSH N/A
  • ARTL N/A
  • Revenue
  • YOSH $11,652,880.00
  • ARTL N/A
  • Revenue This Year
  • YOSH N/A
  • ARTL N/A
  • Revenue Next Year
  • YOSH N/A
  • ARTL N/A
  • P/E Ratio
  • YOSH N/A
  • ARTL N/A
  • Revenue Growth
  • YOSH 25.97
  • ARTL N/A
  • 52 Week Low
  • YOSH $2.71
  • ARTL $0.91
  • 52 Week High
  • YOSH $8.25
  • ARTL $1.75
  • Technical
  • Relative Strength Index (RSI)
  • YOSH 52.84
  • ARTL 64.07
  • Support Level
  • YOSH $2.71
  • ARTL $1.09
  • Resistance Level
  • YOSH $3.62
  • ARTL $1.19
  • Average True Range (ATR)
  • YOSH 0.20
  • ARTL 0.06
  • MACD
  • YOSH 0.07
  • ARTL 0.01
  • Stochastic Oscillator
  • YOSH 85.79
  • ARTL 100.00

About YOSH Yoshiharu Global Co.

Yoshiharu Global Co is a restaurant operator. The company has one reportable segment, consisting of operating its stores. Yoshiharu serves the perfect, ideal ramen, as well as offers customers a wide variety of sushi, bento menus, and other favorite Japanese cuisines. It owns and operates restaurant stores.

About ARTL Artelo Biosciences Inc.

Artelo Biosciences Inc is a United States-based development-stage biopharmaceutical company. It is engaged in development of therapeutics that target lipid signaling pathways, including the endocannabinoid system, a family of receptors and neurotransmitters that form a biochemical communication network in body. It is focused on discovering, licensing, developing, and commercializing treatments that control endocannabinoid systems. The company pursues technologies and programs that offer proprietary approaches to cannabinoid-based therapies, also those derived from the cannabis plant and synthetic cannabinoids, as well as new chemical entities and compounds. The firm's flagship program is designed to be a patent-protected cannabinoid drug combination treatment for a rare and orphan disease.

Share on Social Networks: